Welcome to the Porton Newsroom

Newsletters 2026-09-30

Porton Newsletter - September, 2026 Recap

Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001 PMO Therapeutics: Technical Review and Manufacturing Platform Capabilities

Newsletters 2026-08-31

Porton Newsletter - August 2026 Recap

Porton Reports H1 2026 Results Porton Appoints Dr. Yongli Zhong as Chief Scientific Officer Porton Appoints Yunxing Yin as Corporate Vice President to Strengthen Small-Molecule R&D Leadership

Newsletters 2026-07-31

Porton Newsletter - July 2026 Recap

Antibody-Oligonucleotide Conjugates: From Conjugation Strategy to Purification and Analytical Control Porton Named as a Constituent of the FTSE4Good Index Series

Newsletters 2026-06-30

Porton Newsletter - June 2026 Recap

Porton Newsletter - June 2026 Recap

Newsletters 2026-05-31

Porton Newsletter - May 2026 Recap

Porton Newsletter - May 2026 Recap

Newsletters 2026-04-30

Porton Newsletter - April 2026 Recap

Porton Newsletter - April 2026 Recap

Newsletters 2026-03-31

Porton Newsletter - March 2026 Recap

Porton Newsletter - March 2026 Recap

Newsletters 2026-02-28

Porton Newsletter - February 2026 Recap

Porton Newsletter - February 2026 Recap

Newsletters 2026-02-03

Porton Newsletter - January 2026 Recap

Porton Newsletter - January 2026 Recap